3D Systems Is Now a Player in the 3D Bioprinting Market

3D Systems (NYSE: DDD) stock soared 35% earlier this month after the 3D printing company's release of first-quarter 2021 results that sped by investors' expectations. Excluding divestitures, its revenue jumped 17% year over year, and it was profitable from both an adjusted basis and according to generally accepted accounting principles (GAAP).

While it's still relatively early in the company's turnaround, things have been looking brighter over the last couple of quarters. Revenue is growing, debt is gone, cash flow from operations is positive, and non-core assets are being divested.

One of CEO Jeffrey Graves' smartest moves, however, hasn't received the attention it deserves: increasing the company's push into the burgeoning 3D bioprinting market.

Continue reading

Source Fool.com